Victory Capital Management
DOVA

Victory Capital Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Victory Capital Management’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,084
Closed -$58K – 3735
2019
Q3 		$58K Buy
+2,084
New +$33.8K ﹤0.01% 2621

Victory Capital Management's DOVA Position: Q4 2019 in Review

Victory Capital Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 2,084 shares — an estimated $58K sold.

Victory Capital Management first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $58K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Victory Capital Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Victory Capital Management sold 2,084 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $58K.
  • Victory Capital Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Victory Capital Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $58K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Victory Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.